Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica L Young

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Biochemistry|July 29, 2008
Engineering ribonucleoside triphosphate specificity in a thymidylyltransferaseDavid L Jakeman, Jessica L Young, Malcolm P Huestis, et al.
Journal of Substance Use and Addiction Treatment|October 22, 2025
Impact of a brief personally tailored opioid-overdose and medication for opioid use disorder education intervention on naloxone acceptance in peripartum individuals: A secondary exploratory analysisMichelle R Lofwall, Frankie Kropp, Jasmin Charles, et al.
Substance Use & Addiction Journal|January 2, 2026
Factors Associated With Opioid-Involved Overdose: Descriptive Data From a Randomized Controlled Trial Evaluating Extended-Release Buprenorphine for Perinatal Opioid Use DisorderSara M Witcraft, Leah Holcomb, Yingjia Wei, et al.
Journal of Clinical Gynecology and Obstetrics|March 4, 2024
What to Expect With Pregnant or Postpartum Prescribing of Extended-Release Buprenorphine (CAM2038)Michelle R Lofwall, Jessica L Young, Zachary Hansen, et al.
Drug and Alcohol Dependence|July 23, 2025
Personally-tailored opioid-overdose and medication for opioid use disorder (MOUD) education (TOME) significantly increases MOUD and overdose knowledge in peripartum individuals: Results from a randomized controlled pilot trialT John Winhusen, Frankie Kropp, Marcela C Smid, et al.
JAMA Internal Medicine|March 16, 2026
Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical TrialT John Winhusen, Michelle R Lofwall, Frankie Kropp, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Biochemistry|July 29, 2008
Engineering ribonucleoside triphosphate specificity in a thymidylyltransferaseDavid L Jakeman, Jessica L Young, Malcolm P Huestis, et al.
Journal of Substance Use and Addiction Treatment|October 22, 2025
Impact of a brief personally tailored opioid-overdose and medication for opioid use disorder education intervention on naloxone acceptance in peripartum individuals: A secondary exploratory analysisMichelle R Lofwall, Frankie Kropp, Jasmin Charles, et al.
Substance Use & Addiction Journal|January 2, 2026
Factors Associated With Opioid-Involved Overdose: Descriptive Data From a Randomized Controlled Trial Evaluating Extended-Release Buprenorphine for Perinatal Opioid Use DisorderSara M Witcraft, Leah Holcomb, Yingjia Wei, et al.
Journal of Clinical Gynecology and Obstetrics|March 4, 2024
What to Expect With Pregnant or Postpartum Prescribing of Extended-Release Buprenorphine (CAM2038)Michelle R Lofwall, Jessica L Young, Zachary Hansen, et al.
Drug and Alcohol Dependence|July 23, 2025
Personally-tailored opioid-overdose and medication for opioid use disorder (MOUD) education (TOME) significantly increases MOUD and overdose knowledge in peripartum individuals: Results from a randomized controlled pilot trialT John Winhusen, Frankie Kropp, Marcela C Smid, et al.
JAMA Internal Medicine|March 16, 2026
Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical TrialT John Winhusen, Michelle R Lofwall, Frankie Kropp, et al.
Pageof 2